General Information of Drug Therapeutic Target (DTT) (ID: TTPZGYX)

DTT Name HUMAN colony-stimulating factor (GM-CSF)
Synonyms Sargramostim; Molgramostin; GM-CSF; Colony-stimulating factor; CSF2; CSF
Gene Name CSF2
BioChemical Class
Growth factor
UniProt ID
CSF2_HUMAN
TTD ID
T94514
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVI
SEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITF
ESFKENLKDFLLVIPFDCWEPVQE
Function Cytokine that stimulates the growth and differentiation of hematopoietic precursor cells from various lineages, including granulocytes, macrophages, eosinophils and erythrocytes.
KEGG Pathway
Cytokine-cytokine receptor interaction (hsa04060 )
JAK-STAT signaling pathway (hsa04630 )
Hematopoietic cell lineage (hsa04640 )
Natural killer cell mediated cytotoxicity (hsa04650 )
IL-17 signaling pathway (hsa04657 )
T cell receptor signaling pathway (hsa04660 )
Fc epsilon RI signaling pathway (hsa04664 )
TNF signaling pathway (hsa04668 )
Shigellosis (hsa05131 )
Amoebiasis (hsa05146 )
Human T-cell leukemia virus 1 infection (hsa05166 )
Kaposi sarcoma-associated herpesvirus infection (hsa05167 )
Coronavirus disease - COVID-19 (hsa05171 )
Transcriptional misregulation in cancer (hsa05202 )
Acute myeloid leukemia (hsa05221 )
Rheumatoid arthritis (hsa05323 )
Reactome Pathway
RAF/MAP kinase cascade (R-HSA-5673001 )
Interleukin-10 signaling (R-HSA-6783783 )
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells (R-HSA-8939246 )
Interleukin receptor SHC signaling (R-HSA-912526 )
Interleukin-3, Interleukin-5 and GM-CSF signaling (R-HSA-512988 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Drugs in Phase 3 Trial Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Lenzilumab DMSRIT4 Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 3 Trial [1]
------------------------------------------------------------------------------------
1 Drugs in Phase 2 Trial Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Otilimab DM1AQLW Rheumatoid arthritis FA20 Phase 2 Trial [1]
------------------------------------------------------------------------------------
1 Drugs in Phase 1 Trial Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
TJ003234 DM0VXIM Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 1/2 Trial [1]
------------------------------------------------------------------------------------

References

1 The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19. J Autoimmun. 2020 Apr 17:102468.